Novo stock rises after earnings report
Novo is taking on Eli Lilly in the weight-loss drug market.
The company’s stock rose after its earnings report.
Novo’s move into the weight-loss market is a significant development.
Novo Gains Ground In Weight-Loss Market
Novo stock rises after earnings report Novo is taking on Eli Lilly in the weight-loss drug market. The company's stock rose after its earnings report. Novo's move into the weight-loss market is a significant development.